Psoriasis and cardiovascular risk: Strength in numbers, Part II

Journal of Investigative Dermatology

Volumn 131, Issue 5, 2011, Pages 1007-1010

  Gelfand, Joel M ^a   Mehta, Nehal N ^a   Langan, Sinéad M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); FOLLOW UP; HUMAN; HYPERTENSION; INFORMATION; MORTALITY; OBESITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; RISK ASSESSMENT; STUDY DESIGN;

EID: 79954621289     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.32     Document Type: Note

References (32)

1. Abuabara K, Azfar RS, Shin DB et al. (2010) Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 163:586-92
2. Ahlehoff O, Gislason GH, Charlot M et al. (2010) Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med; e-pub ahead of print 29 November 2010
3. Azfar R, Gelfand J (2008) Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 20:416-22
4. Brauchli YB, Jick SS, Miret M et al. (2009) Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 160:1048-56
5. Britton A, McKee M, Black N et al. (1999) Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy 4:112-21 (Pubitemid 29186862)
6. Card TR, Solaymani-Dodaran M, Hubbard R et al. (2006) Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health 60:819-21 (Pubitemid 44298836)
7. Davidovici BB, Sattar N, Prinz JC et al. (2010) Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130:1785-96
8. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811-21
9. Flegal KM, Graubard BI, Williamson DF et al. (2007) Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298:2028-37 (Pubitemid 350074800)
10. Freis ED (1990) Reminiscences of the Veterans Administration trial of the treatment of hypertension. Hypertension 16:472-5 (Pubitemid 20338543)
11. Friedewald VE, Cather JC, Gelfand JM et al. (2008) AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 102:1631-43
12. Gelfand J, Neimann A, Shin D et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-41 (Pubitemid 44547793)
13. Gelfand J, Dommasch E, Shin D et al. (2009) The risk of stroke in patients with psoriasis. J Invest Dermatol 129:2411-8
14. Gelfand JM, Azfar RS, Mehta NN (2010) Psoriasis and cardiovascular risk: strength in numbers. J Invest Dermatol 130:919-22
15. Hennekens CH, Buring JE (1987) Epidemiology in Medicine. Little, Brown: Boston, MA
16. Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895-902
17. Kimball AB, Gladman D, Gelfand JM et al. (2008) National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58:1031-42
18. Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 60:218-24
19. Love TJ, Qureshi AA, Karlson EW et al. (2010) Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol; e-pub ahead of print 20 December 2010
20. Mehta N, Azfar R, Shin D et al. (2009) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31:1000-6
21. Melski JW, Tanenbaum L, Parrish JA et al. (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 68:328-35 (Pubitemid 8132292)
22. Menter A, Gottlieb A, Feldman SR et al. (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58:826-50 (Pubitemid 351509656)
23. Nijsten T, Looman CW, Stern RS (2007) Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 143:1113-21 (Pubitemid 47443362)
24. Peters MJ, Symmons DP, McCarey D et al. (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325-31
25. Rosamond W, Flegal K, Furie K et al. (2008) Heart disease and stroke statistics\2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25-146
26. Rothwell PM (2005) External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 365:82-93 (Pubitemid 40082150)
27. Seminara NM, Abuabara K, Shin DB et al. (2010) Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol; 104:602-9
28. Stern RS, Huibregtse A (2011) Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol 131:1159-66
29. Strom B (2005) Pharmacoepidemiology. Wiley: New York
30. Xiao J, Chen LH, Tu YT et al. (2009) Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 23:1311-5
31. Xu JQ, Kochanek KD, Murphy SL et al. (2010) Deaths: final data for 2007. Statistics 58:1-135
32. Zhang C, Rexrode KM, van Dam RM et al. (2008) Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117:1658-67 (Pubitemid 351482590)